Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / United Kingdom

GSK To Close Misfiring Puerto Rico Factory

October 2007 | Industry News

UK-based drugmaker GlaxoSmithKline (GSK) has announced that it will close its manufacturing plant in Puerto Rico, becoming the latest multinational to downsize operation in the US-affiliated territory.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
ProStrakan's Sancuso Receives US FDA Approval

Industry / United Kingdom Underlining the UK's rich heritage in developing drugs, Scottish company ProStrakan's granisetron transdermal patch, Sancuso, has been approved by the US FDA for the prevention of chemotherapy-induced...
September 2008
GlaxoSmithKline To Take On Merck & Co In Rotavirus Immunisation Market

Industry / United Kingdom GlaxoSmithKline (GSK) and Merck & Co are set to go head-to-head in childhood rotavirus vaccination, after the US Centre for Diseases Control and Prevention (CDC)'s Advisory Committee on Immunization...
June 2008
Court Case Shakes Up Wholesale Sector

Companies / United Kingdom US-based drugmaker Pfizer has won a key decision in the UK allowing it to supply its product through a single wholesaler. The High Court in London refused to grant an injunction that would have forced...
March 2007
Shire Acquires New River Pharmaceuticals

Companies / United Kingdom UK-based drugmaker is to purchase US-based New River Pharmaceuticals, in a deal worth US$2.6bn as it attempts to consolidate its position in the lucrative attention-deficit hyperactivity disorder (ADHD)...
February 2007
AstraZeneca Takes On MRSA

Companies / United Kingdom Anglo-Swedish drugmaker AstraZeneca is to invest US$100mn in its R&D centre in Boston, Massachussetts. The extra funding will be used primarily for research into new treatments for infections,...
January 2007


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS